QS Investors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

QS Investors’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-105,759	Closed	-$2.01M	–	1724
2019 Q1	$2.01M	Hold	105,759	–	–	0.02%	605
2018 Q4	$1.43M	Hold	105,759	–	–	0.02%	669
2018 Q3	$1.17M	Buy	+105,759	New	+$1.06M	0.01%	773
2017 Q1	–	Sell	-132,027	Closed	-$648K	–	2081
2016 Q4	$648K	Hold	132,027	–	–	0.01%	837
2016 Q3	$655K	Hold	132,027	–	–	0.01%	838
2016 Q2	$672K	Hold	132,027	–	–	0.01%	848
2016 Q1	$754K	Hold	132,027	–	–	0.01%	829
2015 Q4	$1.37M	Buy	132,027 +34,738	+36%	+$471K	0.01%	735
2015 Q3	$1.8M	Hold	97,289	–	–	0.02%	649
2015 Q2	$1.89M	Buy	97,289 +32,028	+49%	+$567K	0.02%	629
2015 Q1	$1.15M	Hold	65,261	–	–	0.01%	712
2014 Q4	$1.04M	Buy	+65,261	New	+$874K	0.01%	721

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

QS Investors's OSIR Position: Q2 2019 in Review

QS Investors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 105,759 shares — an estimated $2.01M sold.

QS Investors first reported a position in OSIR in Q4 2014 and held it in 12 quarters. The position peaked at $2.01M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

QS Investors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
QS Investors sold 105,759 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $2.01M.
QS Investors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2014 and held it in 12 quarters.
QS Investors's Osiris Therapeutics, Inc. Common Stock position peaked at $2.01M in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on QS Investors's 13F filing for Q2 2019, filed 14 Aug 2019.